Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,263.10 -55.12 -0.36%
S&P 500 1,650.49 -1.32 -0.08%
Nasdaq 3,473.39 -8.79 -0.25%
Ticker Volume Price Price Delta
STOXX 50 2,683.98 -16.95 -0.63%
FTSE 100 6,348.82 -25.39 -0.40%
DAX 8,197.08 -32.43 -0.39%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

NPS Pharmaceuticals Inc

+ Add to Watchlist

NPSP:US

14.8200 USD 0.5100 3.33%

As of 14:18:37 ET on 06/19/2013.

Company Profile for NPS Pharmaceuticals Inc (NPSP)

NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of treatment options for patients with rare gastrointestinal and endocrine disorders and serious unmet medical needs.

Contact Information

NPS Pharmaceuticals Inc

550 Hills Drive
3rd Floor
Bedminster, NJ 07921
United States
Phone: 1-908-450-5300

Key Executives for NPS Pharmaceuticals Inc (NPSP)

Francois NaderPresident/CEOLuke Matthew BesharExec VP/CFO
Roger J GarceauExec VP/Chief Medical OfficerEric PauwelsSenior VP/Chief Commercial Ofcr
Edward H StratemeierSenior VP:Legal Affairs/SecySusan GrafVP:Corporate Dev & Strategy

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil